WASHINGTON — Despite a cool reception from Congress, the White House is looking to intensify its pressure campaign on lawmakers to pass legislation that would codify a “most-favored nation” drug pricing policy, according to two Trump administration officials briefed on the conversations.
The administration has been pushing Republicans on Capitol Hill to pursue a sweeping health care package that would mean changes for providers, insurers, federal agencies, and patients. But much of the focus has been on creating legislation aimed at bringing the cost of medications to levels below what other peer countries pay.
So far, lawmakers have been far from receptive to such an idea, with Republicans characterizing the effort as government overreach that would be counter to free-market ideals, one of the officials said. But the White House isn’t backing down.Continue to STAT+ to read the full story…